Downstream Processing Featured Articles
-
Beckman Coulter Life Sciences To Acquire Cytometer Maker Xitogen
4/22/2014
Beckman Coulter Life Sciences has entered into an agreement to acquire Xitogen Technologies Inc. together with Cytojene Corporation. Xitogen, a flow cytometer developer based in Suzhou and Dalian, China, will provide Beckman Coulter Life Sciences with both a strong operational base in the growing China market and a high quality research instrument to round out their world-class cytometry offering.
-
MorphoSys Receives First Patent On Novel Antibody Platform Ylanthia In The US
2/8/2013
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) today announced that the US Patent and Trademark Office (USPTO) has granted the first patent covering the Company's latest antibody platform Ylanthia, which became commercially available for existing and new partners in 2012.
-
Biotest Pharmaceuticals Announces Strategic Long-Term Manufacturing, Supply And License Agreement
1/10/2013
Biotest Pharmaceuticals Corp. (BPC), a wholly owned U.S. subsidiary of Biotest AG (Dreieich, Germany), recently announced it has entered into a strategic long-term manufacturing, supply, and license agreement with ADMA Biologics,Inc.(ADMA).
-
Bioresearch Online Interview With Kirby Pilcher And Dr. George Rodrigues, ARTEL
3/20/2007
The editorial staff recently sat down with Kirby Pilcher and Dr. George Rodrigues to discuss liquid handling quality assurance and the solutions that are available to avoid potentially expensive and risky pipetting disasters. Kirby is the President and Dr. George Rodrigues the Senior Scientific Manager of ARTEL in Westbrook, ME. Enjoy the discussion
-
Refine Technology And Gallus BioPharmaceuticals To Collaborate On Continuous BioManufacturing
1/22/2013
Refine Technology, LLC (Refine), the developer and worldwide supplier to the biotech industry of the ATF™ System, a best-in-class cell retention device, and Gallus BioPharmaceuticals, LLC (Gallus), the industry leading contract bulk biopharmaceuticals manufacturer, today announced a collaboration to optimize continuous cell culture processes.
-
NIH-Funded Researchers Create Next-Generation Alzheimer’s Disease Model
4/9/2013
A new genetically engineered lab rat that has the full array of brain changes associated with Alzheimer’s disease supports the idea that increases in a molecule called beta-amyloid in the brain causes the disease, according to a study, published in the Journal of Neuroscience.
-
Waters UltraPerformance Convergence Chromatography Ushers In New Category Of Separation Science At Pittcon
3/13/2012
Waters Corporation recently drew back the curtain on several important new technologies and a new business venture at Pittcon 2012, the industry’s most important annual new product conference and exhibition.
-
New Strategy Prevents Rheumatoid Arthritis In Mice
2/8/2013
Dana-Farber Cancer Institute scientists have demonstrated a new strategy for treating autoimmune disease that successfully blocked the development of rheumatoid arthritis in a mouse model.
-
Untapped Potential Of Protein A To Be Highlighted At BPI Conference
8/19/2015
Pete Gagnon, group manager for downstream processing at the Bioprocessing Technology Institute in Singapore, discusses his upcoming presentation at the 2015 BioProcess International (BPI) Conference. Protein A: the Fine Print, is one of several scheduled during the pre-conference symposia track, Innovation in Process and Product Development Technologies for Biopharmaceutical Development.
-
The Real Threat To Biopharma Supply Chains: Bioprocessing Materials
5/12/2020
The COVID-19 induced risk to biopharma is not a shortage of pharmaceutical ingredients. It’s the constricting supply of consumable materials and equipment necessary to produce therapies from them. Mike Piccarreta, Partner at Kearney, offers an outlook and practical advice on supply stabilization in this BioProcess Online exclusive.